GB874209A - Improvements relating to the production of benzimidazolylidene compounds and the resulting products - Google Patents

Improvements relating to the production of benzimidazolylidene compounds and the resulting products

Info

Publication number
GB874209A
GB874209A GB39631/57A GB3963157A GB874209A GB 874209 A GB874209 A GB 874209A GB 39631/57 A GB39631/57 A GB 39631/57A GB 3963157 A GB3963157 A GB 3963157A GB 874209 A GB874209 A GB 874209A
Authority
GB
United Kingdom
Prior art keywords
benzimidazole
methyl
group
nitro
aldehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB39631/57A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
JR Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JR Geigy AG filed Critical JR Geigy AG
Publication of GB874209A publication Critical patent/GB874209A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Benzimidazolylidene compounds are prepared by condensing a benzimidazole-2-aldehyde, unsubstituted in the benzene ring, with an organic compound containing an activated methyl or methylene group and having the general formula X-CH2-Y as hereinafter defined, if necessary in the presence of an acid or basic condensation catalyst, with splitting off of water. The organic compounds containing an activated methyl or methylene group are those in which X represents an electrophilic group such as a carbonyl, carboxyl, carboxylic ester, carboxylic amide, cyano, nitro or organic ammonium group, an aromatic-heterocyclic containing tertiary nitrogen, or a negatively substituted-aromatic isocyclic radical, and Y represents hydrogen, an inert organic group or an electrophilic group. Specified compounds include acetophenone, phenylacetic acid, benzyl cyanide, cyano acetic esters and amides, open and cyclic 1:3-diketones, malonic esters and amides including cyclic amides such as 1:3-diketo pyrazolidines, acyl acetic esters and amides including cyclic amides such as the 5-pyrazolones, heterocyclic compounds containing an activated methyl group in the o- or p-position to a tertiary N atom, preferably in the form of a cyclammonium salt form, such as methylsubstituted pyridines, pyrimidines, pyridazine, pyrazine, azophenanthrene, quinolines, benzthiazoles, benzoxazoles and benzimidazoles, and 4-nitro-1-methyl benzenes having a negative group in the 2-position, e.g. an alkyl sulphonyl, sulphonic acid ester, sulphonamide or cyano group. The benzimidazole-2-aldehydes may be 1-substituted by, for example, lower alkyl groups such as inter alia methyl, butyl, cyano-, hydroxy- or ethoxy-ethyl groups. The condensation is effected under the usual conditions for the condensation of an aldehyde with an active-methyl or -methylene compound. Suitable catalysts are nitrogen bases, caustic alkalies, alkali metal alcoholates, zinc chloride, boric acid, fluoboric acid, sulphuric acid and hydrogen chloride. In some cases a reactant serves as catalyst (of Examples 9, 10 and 14). The water formed may be removed by an entrainer or a fatty acid anhydride. The products obtained from the heterocyclic compounds containing an activated methyl group are optical brightening agents. The compounds obtained from the 4-nitro-1-methyl benzenes may be converted into brightening agents by reducing the nitro-group and then reacting the amino group with an acylating agent, potassium cyanate or a cyanuric halide. The compounds prepared from araliphatic ketones may be reacted with aryl hydrazines to give fluorescent 1:3-diaryl-5-benzimidazolyl-pyrazolines. In the examples, benzimidazole-2-aldehyde is condensed with (1) 2-methyl sulphonyl-4-nitro toluene, the product being reduced to the amino-compound which is reacted with acetic anhydride or potassium cyanate, (4) acetophenone, (5) 1:2-dimethyl benzimidazole, (6) 1-ethyl-2-methyl benzimidazole or (12) 1-b -hydroxy ethyl-2-methyl benzimidazole; 1-methyl benzimidazole-2-aldehyde is condensed with (2) 4-nitro-2-methyl sulphonyl toluene, the product being reduced to the corresponding amino compound which is reacted with acetic anhydride, potassium cyanate or diglycollic acid anhydride, (3) the phenyl ester of 4-nitro toluene-2-sulphonic acid, the product being saponified and reduced to convert the nitro-group to -NH2 which is then acylated, (5) 2-methyl benzimidazole, (6) 1:2-dimethyl benzimidazole, (7) 2:5-dimethyl benzoxazole yield a product existing in cis- and trans-forms which are separated, the cis-form being converted into the optical brightening trans-form on heating, (8) quinaldine, (9) 1:2-dimethyl quinolinium iodide, (10) 2 : 3 - dimethyl - benzthiazolium iodide, (12) 1-b -hydroxy ethyl -2-methyl benzimidazole and (14) 1-ethyl-2-methyl benzimidazole, part being in hydrochloride form as catalyst; (11) 1-ethyl benzimidazole-2-aldehyde is condensed with 1:2-dimethyl benzimidazole and (13) 1-phenyl benzimidazole is condensed with 1:2-dimethyl or 2-methyl benzimidazole. Other 2-methyl benzimidazole reactants are specified containing chlorine in the benzene ring. Benzimidazole-2-aldehyde reactants are prepared by reacting suitable 1:2-diamino benzenes with glyoxylic acid alkyl ester dialkyl acetals and then saponifying the acetal group or by condensing the diamino benzenes or their hydrohalic salts with dichloro- or dibromo-acetic acid and saponifying the resulting 2-dihalo benzimidazole.ALSO:Optical brightening and sometimes dyeing of such materials as wool, fibres of cellulose, polyacrylonitriles, polyesters and polyamides, and cotton and nylon fabrics is effected by means of benzimidazolyl compounds prepared by condensing a benzimidazole- 2-aldehyde, unsubstituted in the benzene ring, with an organic compound containing an activated methyl or methylene group which is (1) a heterocyclic compound having a methyl group in the o-or p-position to a tertiary nitrogen atom in the ring, this nitrogen preferably being in the form of a cyclammonium salt, such as a methyl substituted pyridine, pyrimidine, pyradazine, pyrazine, quinoline, azophenanthrene, benzoxazole, benzthiazole or benzimidazole, (2) an araliphatic ketone, the product then being condensed with an aryl hydrazine to yield a fluorescent 1 : 3-diaryl- 5-benzimidazolyl-pyrazoline, or (3) a nitro-toluene having an activating negative substituent such as an alkyl sulphonyl, sulphonic acid ester, sulphonamide or cyano group, the resulting nitro styryl-benzimidazole product being converted into the desired brightening agent by reduction of the nitro-group to the amino-group followed by reaction of the latter with an acylating agent, e.g. acetic anhydride or diglycolic acid anhydride, or with a cyanuric halide or potassium cyanate. The condensation of the benzimidazole- 2-aldehyde is effected with splitting-out of water, if necessary with the aid of a basic or acidic condensation catalyst. The aldehyde may be substituted in the 1-position by, for example, a lower alkyl, hydroxyethyl, methoxy- or ethoxy ethyl, cyanoethyl or hydroxypropyl group. Numerous examples of the brightening agents are given. The compounds prepared from 1-methylbenzimidazole- 2-aldehyde and 1 : 2-dimethyl-quinolinium iodide and 2 : 3-dimethyl-benzthiazolium iodide dye cellulose and polyacrylonitrile fibres a fluorescent yellow colour.
GB39631/57A 1956-12-21 1957-12-20 Improvements relating to the production of benzimidazolylidene compounds and the resulting products Expired GB874209A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH874209X 1956-12-21

Publications (1)

Publication Number Publication Date
GB874209A true GB874209A (en) 1961-08-02

Family

ID=4544271

Family Applications (1)

Application Number Title Priority Date Filing Date
GB39631/57A Expired GB874209A (en) 1956-12-21 1957-12-20 Improvements relating to the production of benzimidazolylidene compounds and the resulting products

Country Status (4)

Country Link
CH (1) CH348967A (en)
DE (1) DE1077222B (en)
FR (1) FR1195348A (en)
GB (1) GB874209A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007091056A2 (en) * 2006-02-07 2007-08-16 The University Of York Bicyclic compounds and their use
US20150166571A1 (en) * 2010-05-26 2015-06-18 Sunovion Pharmaceuticals Inc. Heteroaryl Compounds and Methods of Use Thereof
CN108047139A (en) * 2017-11-13 2018-05-18 云南民族大学 A kind of chalcone-benzimidazole salt compound and its preparation

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1419330A1 (en) * 1962-06-09 1970-02-19 Hoechst Ag Optical brighteners

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE883286C (en) * 1942-12-23 1953-07-16 Ciba Geigy Process for the preparation of diimidazoles
NL61062C (en) * 1942-12-23

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007091056A2 (en) * 2006-02-07 2007-08-16 The University Of York Bicyclic compounds and their use
WO2007091056A3 (en) * 2006-02-07 2008-01-03 Univ York Bicyclic compounds and their use
US20150166571A1 (en) * 2010-05-26 2015-06-18 Sunovion Pharmaceuticals Inc. Heteroaryl Compounds and Methods of Use Thereof
US9834564B2 (en) * 2010-05-26 2017-12-05 Sunovion Pharmaceuticals Inc. Substituted quinolines as PDE-10 inhibitors
US10562916B2 (en) 2010-05-26 2020-02-18 Sunovion Pharmaceuticals, Inc. Substituted quinoxalines as PDE-10 inhibitors
CN108047139A (en) * 2017-11-13 2018-05-18 云南民族大学 A kind of chalcone-benzimidazole salt compound and its preparation
CN108047139B (en) * 2017-11-13 2023-04-28 云南民族大学 Chalcone-benzimidazole salt compound and preparation thereof

Also Published As

Publication number Publication date
CH348967A (en) 1960-09-30
FR1195348A (en) 1959-11-17
DE1077222B (en) 1960-03-10

Similar Documents

Publication Publication Date Title
GB874209A (en) Improvements relating to the production of benzimidazolylidene compounds and the resulting products
US3637734A (en) Benzimidazolylfuran compounds
US3470167A (en) Triazolyl styryl optical whitening agents
US3772323A (en) 2-benzimidazol(2)-benzofurans as optical brighteners
US3865816A (en) 3-(3{40 ,4{40 -Dichloro-6{40 -alkyl-phenyl)-delta, 2-pyrazoline derivatives
GB938029A (en) Improvement in the production of diaza polymethine dyes
GB932022A (en) New tetrazapolymethine dyes
US3497525A (en) 2-furylbenzimidazolyl compounds
US3637672A (en) Azole compounds
US3798234A (en) Process for the preparation of 3-anilino-pyrazolones-(5)
US3784570A (en) 4-chloropyrazolyl compounds
JPH08245540A (en) Cyanization of double bond system
US3711506A (en) Substituted 3-aminoindazoles
US3635960A (en) Para-phenylthidiazolyl- and para-phenyloxdiazolyl derivatives of styrylbenzoxazoles or of styrylbenzothiazoles
US3427307A (en) Benzoxazole optical brighteners
US4271293A (en) Benzofuranyl-benzimidazoles
US3405136A (en) 1-phenylsulfonyl-2-benzimidazo-linones and 1-phenylsulfonyl-2-benzimidazolinethiones
JPS61261489A (en) Synthesis of azo compound
US3549626A (en) Process for preparing 1-loweralkyl-5-nitroimidazoles
US4197401A (en) Stilbenes, process for the manufacture thereof and the use thereof as optical brighteners
US3595859A (en) 5-arylotriazolyl-2-styryl-benzotriazoles
JPS5923348B2 (en) Benzimidazole derivatives and their production and use
GB990397A (en) New azolylthiophene compounds useful as optical brightening agents and process for their production
US3873528A (en) Indoline dyestuffs
GB1477277A (en) Process for the manufacture of heterocyclic substituted styrenes heterocyclic substituted styrenes and their use as optical brighteners